GeoVax Commences Site Expansion For Phase 2 Trial Of Next-Generation Covid-19 Vaccine

GEOVAX LABS INC +1.56%

GEOVAX LABS INC

GOVX

1.95

+1.56%

Designed to Protect Immunocompromised Patients Against Severe COVID-19

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via